Related Experiment Video
Updated: Apr 25, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Managing hypertension in patients with chronic kidney disease
Kim Zuber1, Cheryl Gilmartin, Jane Davis
1Kim Zuber practices at Metropolitan Nephrology in Alexandria, Va., and is CME chair of the National Kidney Foundation. Cheryl Gilmartin is a clinical assistant professor in the departments of pharmacy practice and nephrology at the University of Illinois Hospital and Health Sciences System in Chicago, Ill. Jane S. Davis is a nurse practitioner at the University of Alabama at Birmingham and a member of the National Kidney Foundation board. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Insights
Managing hypertension in chronic kidney disease (CKD) is crucial for preventing cardiovascular events. Effective strategies include sodium restriction and specific medications like renin-angiotensin-aldosterone inhibitors and calcium channel blockers.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) and hypertension share a strong, intrinsic link.
- Cardiovascular events are the primary cause of mortality in CKD patients, despite high lifetime diagnosis rates.
- Effective hypertension management is vital for improving outcomes in CKD.
Purpose of the Study:
- To outline the relationship between CKD and hypertension.
- To identify effective management strategies for hypertension in CKD patients.
Main Methods:
- Review of current medical literature on CKD and hypertension.
- Analysis of established treatment protocols for hypertension in CKD.
Main Results:
- Sodium restriction is a key component in managing hypertension in CKD.
- A combination therapy including renin-angiotensin-aldosterone system (RAAS) inhibitors and calcium channel blockers (CCBs) demonstrates significant efficacy.
Conclusions:
- Integrated management of hypertension is essential for CKD patients.
- Pharmacological and dietary interventions, specifically sodium restriction and combined RAAS/CCB therapy, are recommended for optimal patient outcomes.
Abstract:
Chronic kidney disease (CKD) and hypertension are intrinsically linked. Although 59% of the US population will be diagnosed with CKD during their lifetimes, mortality is usually due to a cardiovascular event. Sodium restriction and a combination of a renin-angiotensin-aldosterone medication and a calcium channel blocker are the most effective methods of managing hypertension in patients with CKD.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hypertension V: Nursing Management
Acute Kidney Injury VI: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications

